Card image cap

Sheldon Whitehouse's Public Statements on Issue: Drugs

Office:

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 3
Date Title
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/20/2022 Letter to Jagjit Pavadia, President of the International Narcotics Control Board - Senate Drug Caucus Chairs Call On International Panel To Push For Scheduling Of Dangerous Methamphetamine Precursor Chemical
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis
04/19/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Senator Markey Leads Colleagues in Urging Fda to Ban Menthol Cigarettes
04/16/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Feinstein, Markey, Colleagues Urge FDA to Ban Menthol Cigarettes
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Postmaster General Louis De Joy - Reed & Whitehouse Press Postmaster General to Restore On-Time Delivery and Stop Harmful Changes
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
10/01/2020 Letter to the Hon. William Barr, Attorney General of the United States - Whitehouse, Hassan Call on Justice Department to Hold Purdue Accountable in Newly Revealed Settlement Negotiations
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
04/16/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
10/29/2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
10/23/2019 Letter to the Hon. Mitch McConnell, Majority Leader of the United States Senate, Letter to the Hon. Charles Schumer, Minority of the United States Senate - Capito, Manchin Lead Bipartisan Effort to Extend Funding for Community Health Centers
09/19/2019 Letter to the Hon. Stephen E. Boyd, Assistant Attorney General - Senators Hassan, Whitehouse press Justice Department for 2006 Purdue Pharma prosecution memo
07/11/2019 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Durbin, Lee, Senators Press HHS About Public Health Impact Of "Fentanyl-Related" Scheduling
03/28/2019 Letter to Dr. Craig Landau, President and CEO of Purdue Pharma L.P. - Manchin Asks Purdue Pharma to Commit to Not Profitting from New Drug that Could Reverse Opioid Overdoses
10/29/2018 Letter to the Hon. Scott Gottlieb, Comissioner of the Food and Drug Administration - Wyden, Durbin, Murray & Colleagues Urge FDA to Protect Kids from Tobacco Use and Addiction
09/20/2018 Letter to the Hon. Mitch McConnell, Majority Leader, the Hon. Charles Schumer, Minority Leader, the Hon. Lamar Alexander, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, and the Hon. Patty Murray, Ranking Member of the Senate Committee on Health, Education, Labor, and Pensions - Portman, Whitehouse Call on House-Senate Negotiators to Strengthen Opioids Bill With CARA 2.0 Provisions
08/22/2018 Letter to Uttam Dhillon, Acting Administrator of United States Drug Enforcement Administration - Senators Hassan and Whitehouse Seek Information Regarding Rudy Giuliani's Potential Conflicts of Interest in Representing Purdue Pharma
08/22/2018 Letter to the Hon. Jeff Sessions, Attorney General of the United States - Senators Hassan and Whitehouse Seek Information Regarding Rudy Giuliani's Potential Conflicts of Interest in Representing Purdue Pharma
05/30/2018 Letter to the Honorable Gene L. Dodaro, Comptroller General for the U.S. Government Accountability Office - Senator Markey Leads Bipartisan Call for Assessment of Drug Treatment Availability and Effectiveness in Correctional Facilities
Page 1 of 3
arrow_upward